Zenas BioPharma (ZBIO) Price to Sales (2024 - 2026)
Zenas BioPharma's (ZBIO) Price to Sales was 1607.33 for Q2 2026, compared with 27.19 a year earlier.
Powered by 
Analysis
Zenas BioPharma (ZBIO) Price to Sales (2024 - 2026) Analysis & Trends
For FY2025, Price to Sales at Zenas BioPharma was 162.41, up 651.2% from FY2024.
- By year, Price to Sales came in at 21.62 in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Zenas BioPharma | 1.79 Bn | 1.79 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,607.33 |
| Dec 31, 2025 | 162.41 |
| Sep 30, 2025 | 62.48 |
| Jun 30, 2025 | 27.19 |
| Mar 31, 2025 | 22.03 |
| Dec 31, 2024 | 21.62 |
| Sep 30, 2024 | 2.60 |
API Access
Zenas BioPharma Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ZBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ZBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ZBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();